This brand name is authorized in United States
The drug DETECTNET contains one active pharmaceutical ingredient (API):
|
1
Copper ⁶⁴Cu oxodotreotide
UNII N3858377KC - COPPER OXODOTREOTIDE CU-64
|
|
Copper ⁶⁴Cu oxodotreotide binds to somatostatin receptors with highest affinity for subtype 2 receptors (SSTR2). It binds to cells that express somatostatin receptors including malignant neuroendocrine cells, which overexpress SSTR2 receptors. Copper ⁶⁴Cu oxodotreotide is a positron (β+) emitting radionuclide with an emission yield that allows positron emission tomography (PET) imaging. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| DETECTNET Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: US | FDA, National Drug Code | Identifier(s): 69945-064 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
